CompletedPhase 3NCT06582524
Pegzilarginase in Subjects <24 Months Old With Arginase 1 Deficiency
Studying Argininemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Immedica Pharma AB
- Principal Investigator
- Mattias Rudebeck, PhD MSc BMedScImmedica Pharma AB
- Intervention
- Pegzilarginase(drug)
- Enrollment
- 3 enrolled
- Eligibility
- All sexes
- Timeline
- 2024 – 2025
Study locations (3)
- Univ. Klinik für Kinder- und Jugendheilkunde Medizinische Universität, Graz, Austria
- Unidade de Doenças Metabólicas Pediatria, Hospital Santa Maria, Lisbon, Portugal
- Bradford Royal Infirmary Duckworth Lane, Bradford, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06582524 on ClinicalTrials.gov